Introduction
Hysterectomy without oophorectomy has been traditionally considered protective against ovarian cancer, supported by a considerable body of older research (summarized in (1-3) ).
However, many studies including women diagnosed more recently have not seen a protective association; indeed, some reported modest increases in risk, as seen in a recent meta-analysis (4) and subsequent studies (5, 6) . This apparent shift could arise from changing surgical practices or patient characteristics, changes in menopausal hormone therapy (MHT) use, or perhaps improved reporting of oophorectomy status.
Hysterectomy is one of the most common major surgeries among women globally (7, 8) ; understanding the true relationship between hysterectomy alone and ovarian cancer risk is important to inform the current debate over the relative advantages of prophylactically removing ovaries at hysterectomy. Our aim was to explore the association between hysterectomy for benign indications and ovarian cancer risk, overall and by time period, age at surgery, hysterectomy type, and indication for hysterectomy. We examined this question using 45 years of administrative data from the Western Australian Data Linkage System (WADLS) (9) .
Methods

Study population and linkage
We conducted a retrospective cohort study including all women on the Western Australian (WA) Electoral Roll (enrollment to vote is compulsory) when electronic records began in 1988, or who registered subsequently. We restricted the cohort to women aged ≤45 years in 1975, when hysterectomy began to be reliably recorded, to minimize inclusion of or data inconsistencies (implausible birthdates, births after hysterectomy, first electoral record after death, or male-specific codes: n=1313).
The study received approval from QIMR Berghofer and WA Health Human Research Ethics Committees.
Variable measurement
Our main outcome was diagnosis of primary invasive epithelial cancer in the ovary The HMDC contains information on all public and private WA hospital separations, including admission/discharge month and year, diagnosis codes (principal, 21 additional), and surgical procedure codes (principal, 10 additional) (see Supplementary Tables 1 and 2 for codes). We used procedure codes to ascertain hysterectomies, oophorectomies, and tubal ligations, and diagnosis codes to identify hysterectomy indications and ovarian cancer diagnoses before cancer registry records began.
Birth-year (from electoral records) was provided in 5-year bands to protect anonymity; we derived age by assigning birthdate as the lowermost end. Electoral records include postcode, from which we derived remoteness of residence (major cities/inner regional/outer regional/remote/very remote) using the Accessibility and Remoteness Index of Australia (ARIA+) (10, 11) , and socio-economic disadvantage quintiles using the Socio-Economic Indexes for Areas (SEIFA) (12) , at study entry. We determined parity using the Births Register and MNS, assuming nulliparity at 1950 for women (n=68,218) who reached reproductive age before records began.
Statistical analysis
We calculated person-time for each woman as the interval between study entry (her first appearance in the available electoral records) and exit, determined as the earliest of: ovarian cancer diagnosis; hysterectomy or unilateral/bilateral oophorectomy if followed within 6 months by ovarian cancer diagnosis (surgery date was then assigned as diagnosis date, as we considered these surgeries were likely related to their cancer); or a censoring condition, at which follow-up ceased. Censoring conditions were: all other unilateral/bilateral oophorectomies (including at hysterectomy); hysterectomy for other malignancies (predominantly endometrial); diagnosis of non-epithelial ovarian cancer; death; emigration; or end of observation (30/06/2015) . We calculated exposed and unexposed person-time considering hysterectomy, parity, and tubal ligation as time-varying using the counting process method (13) . Thus person-time from entry until hysterectomy (or until exit, for 7 unexposed women) was considered unexposed; any observed time after hysterectomy (from study entry, for women with prior hysterectomies) was considered exposed.
We performed Cox proportional-hazards regression, estimating hazard ratios (HRs) and 95% confidence intervals (CI) for the association between hysterectomy and ovarian cancer incidence, overall and for different histologic subtypes, using age as the underlying time scale (14) . We stratified models by birth decade, and adjusted for age at entry, parity (≥3 vs 0-2 births), and tubal ligation (yes/no). We omitted SEIFA and ARIA from final models because they did not change HRs for the main association. The proportional hazards assumption was confirmed graphically by plotting Schoenfeld residuals against time.
We conducted additional analyses comparing risk associated with hysterectomy We conducted sensitivity analyses, including: varying elements of the methods (using years as the time-scale); varying the population (to women <45 years when hospital [1970] or Analyses were performed in SAS 9.4 (SAS Institute Inc., N.C.). Tests of statistical significance were two-sided and we used an alpha level of 5% to determine statistical significance; to determine the statistical significance of the hazard ratios in our analysis, we assessed whether the 95% CI crossed 1.00.
Results
We Table 3 . There were too few cancers to conduct period, age, or surgical type analyses by histologic subtype.
Our two a priori approaches to assess whether the association varied by indication were: first, to adjust the main models for the indication(s) for hysterectomy; and second, to examine in a separate model the association between hysterectomy for each indication coded at surgery (a single multi-level variable) and risk, compared to no hysterectomy. Implementing the first approach, we observed that after adjusting models for ever-diagnosis of (Supplementary Table 4) .
To distinguish the effect of hysterectomy for a particular indication from the effect of the condition itself, we implemented a third approach, stratifying by each condition and repeating our analysis within those strata. We observed that among women ever diagnosed with Table 5 ). The strong inverse relationship among women with endometriosis or fibroids remained, although was slightly attenuated, after excluding women with the other condition (data not shown). Among women without endometriosis, without fibroids, and with neither condition, there was no protective effect of hysterectomy (for example, HR 1.15, 95%CI 0.98-1.35, overall, among women with neither condition) ( Table 4 ). In women with prolapse, the effect estimate was slightly elevated but not statistically significant (HR 1.24, 95%CI 0.91-1.69) ( Table 4) .
Our results were robust to the method used to estimate person-years. Including older women (relaxing/removing the age restriction) yielded similar estimates although some became slightly inverse (Supplementary Table 6 ), consistent with the hypothesis that including older women increases misclassification of women with prior oophorectomy.
Restricting analyses to younger women (<45 in 1982), or excluding women migrating into WA, made little difference to estimates (Supplementary Table 6 ). There were no obvious patterns by birth cohort, although numbers were generally too low to draw clear conclusions.
Estimates were similar when we repeated analyses defining outcome strictly as cancer of the ovary (ICD code C56), except for a stronger inverse association for mucinous cancers (data not shown).
Discussion
In this large retrospective study using linked administrative data we found that hysterectomy was not associated with decreased ovarian cancer risk either overall or for the most common and aggressive form (serous cancer), and that reductions in risk were not observed in earlier time periods. There was a suggestion of decreased risk of non-serous ovarian cancers which was not statistically significant. The association varied minimally by age at surgery or type of hysterectomy. Among women with endometriosis or fibroids, two common indications for this procedure, hysterectomy was associated with substantially decreased ovarian cancer risk.
While older studies had suggested a protective effect of hysterectomy on ovarian cancer (18, 19) , almost all recent studies have not shown this (20, 21) . Our results are consistent with recent findings; we did not see inverse associations even for hysterectomies performed in the 1970s/1980s. The discrepancy between older and newer studies may arise from better selfreporting of oophorectomy. Many women with documented bilateral oophorectomy report that their ovaries have not been removed (22) . It may be that women in older studies, with hysterectomies undertaken further back in time, were less likely to be aware that oophorectomy had been simultaneously performed. Our study avoids this bias by ascertaining oophorectomy using hospital records.
Fluctuations in MHT use may have also influenced associations over time. MHT is prescribed more frequently to women with hysterectomy than those without, and is associated with modestly increased ovarian cancer risk (23) . Two large studies have reported that hysterectomy is associated with slightly increased ovarian cancer risk among ever-users of MHT, but decreased risk among never-users (24, 25) . Without data on MHT use we could not Some previous studies have suggested that hysterectomy at younger ages particularly (<45 or <50) may be associated with reduced ovarian cancer risk (4) . However, we found little variation in the association by surgery age.
We found some evidence that the association varies by histologic subtype, with no association seen for serous cancers but a suggestion of inverse relationships with non-serous tumors, particularly mucinous and clear cell. These results closely match subtype-specific estimates from a recent pooled analysis of 21 cohorts (6). Some (5, (26) (27) (28) , but not all (29, 30), large case-control studies have also reported risk reductions for non-serous tumors.
A novel finding of our study was that hysterectomy appeared to substantially reduce risk among women with endometriosis or fibroids (both of which were associated with considerably increased ovarian cancer risk in our population). Few studies have considered indication for hysterectomy. One case-control study reported that adjustment for endometriosis, fibroids, and ovarian cysts decreased the odds ratio for the hysterectomy/ovarian cancer association (24), as we found. An analysis pooling four casecontrol studies (2098 cases) compared women with/without endometriosis and, consistent with our results, reported that hysterectomy was associated with possible decreased ovarian cancer risk among women with endometriosis (OR 0.69, 95%CI 0.38-1.24) but not without (OR 1.02, 95%CI 0.86-1.23) (31). Use of self-reported endometriosis, consequently including a broader disease spectrum with more misclassification, may explain their weaker association, as self-reported endometriosis is associated with lower ovarian cancer risk than surgically confirmed endometriosis (32) . Another study of women with endometriosis found that removal of endometriotic lesions substantially reduced ovarian cancer risk, while hysterectomy did not (33) . It is possible that the protective effect we observed is primarily due to simultaneous removal of lesions. Fibroids have rarely been assessed in relation to ovarian cancer. One Danish record-linkage study reported that women with fibroids are at increased risk of ovarian cancer (RR 1.36, 95%CI 1.16-1.60), particularly endometrioid tumors (RR 1.57, 95%CI 1.05-2.34) (34), a similar although slightly weaker association than we observed. We know of no studies examining the hysterectomy/ovarian cancer relationship by the presence/absence of fibroids. Our findings among women with these conditions, while intriguing and plausible, were obtained from post-hoc subgroup analyses and require replication.
Notable strengths of our study include its large size, population-based design, long-term follow-up, and measurement of exposure and outcome using medical records. Compulsory electoral enrollment allowed us to include virtually all female WA residents. Ascertaining hysterectomy/oophorectomy status using hospital data eliminates recall error, a concern in many previous studies. Misclassification of hysterectomy status is likely to be minimal, since: the HMDC records all surgeries in WA; residents infrequently receive care elsewhere due to geographic isolation (35); we restricted the analysis to younger women at the start of hospital records; and excluding women migrating into WA during observation did not change our findings. Precise information on surgery date allowed accurate classification of exposed time.
Reporting diagnoses of malignant solid tumors to the cancer registry is mandatory, so most ovarian cancers after 1982 should be captured.
Our study is not without limitations. We may not have captured exposures or outcomes occurring prior to available hospital records. We mitigated this by restricting to women aged ≤45 years in 1975 (the start of reliable hysterectomy data). Residual misclassification resulting from unrecorded early hysterectomies (perhaps chiefly among 6.7% of women without recorded hysterectomy, who entered in 1988 and were aged 30-45 in 1975) would have reduced the difference between exposed and unexposed groups, attenuating any association. However, restricting our analysis to younger women resulted in similar estimates, suggesting that misclassification was minimal. Our study design limited access to information on some possible confounding factors, which are not usually recorded in administrative data sources. However, the confounders we were able to include had negligible influence on our effect estimates, and confounders which were unrecorded would be expected to have modest effects (for instance, oral-contraceptive use is not strongly related to hysterectomy [for example, (36) In summary, we conducted a large, population-based record-linkage study using up to 45 years of data for women in Western Australia. Our results for women with endometriosis and fibroids require replication, but suggest that hysterectomy may reduce ovarian cancer risk among these women. However, women without these conditions should not be advised that hysterectomy alone will reduce their ovarian cancer risk. 
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Notes
The funders had no role in: the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. For each histologic subtype analysis, follow-up time is censored at diagnosis of other subtypes. HR = hazard ratio; CI = confidence interval. † Models were stratified by decade of birth and adjusted for age at study entry, tubal ligation (yes/no), and parity (3 or more vs 0-2 births) (Adjustment 1), and additionally endometriosis (yes/no) and fibroids (yes/no) (Adjustment 2). Adjusting for genital prolapse (a third common indication for hysterectomy) did not affect the association between hysterectomy and ovarian cancer, so this was not included in presented models. ‡ As hysterectomy is time-varying, the analysis compares exposed time ('hysterectomy', contributed by women after their hysterectomy) vs unexposed time ('no hysterectomy', contributed by women before their hysterectomy and by women who did not have a recorded hysterectomy). We assigned date of hysterectomy as date of hospital discharge. For the vast majority (99.9%) of the women in this analysis, admission and discharge dates for hospitalisation for hysterectomy were identical (78.9%) or only one month apart (21.0%), because recovery in hospital after hysterectomy is typically short and the provided HMDC data included admission/discharge month and year (not day). cancer includes primary ovarian, fallopian tube, and peritoneal cancer. † Models were stratified by decade of birth and adjusted for age at study entry, tubal ligation (yes/no), and parity (3 or more vs 0-2 births). HR = hazard ratio; CI = confidence interval. ‡ We created a single time-varying variable for hysterectomy by indication. We defined indication using codes recorded in any of the diagnosis fields at the time of surgery, in order to capture the pathological context of the surgery as completely as possible. Women who had a hysterectomy before study exit contribute exposed time to one of the indication categories from their hysterectomy onwards. For each of the following categories, other conditions, such as those coded as uterine disorders or disorders of menstruation, may have been also noted in the hospital record. Hysterectomy is time-varying. Ovarian cancer includes primary ovarian, fallopian tube, and peritoneal cancer. Models were stratified by decade of birth and adjusted for age at study entry, tubal ligation (yes/no), and parity (3 or more vs 0-2 births). In B, patterns were similar if we assigned birthdate at the electoral birth-year band midpoint. 
